Table 4.
Characteristics of patients who received treatment by 12 months of eligibility at a community GI clinic and a university liver clinic
| Total treated by 12 months (n=316) | Community GI clinic (n=219) | University liver clinic (n=97) | p Value | |
|---|---|---|---|---|
| Mean age (years) | 45±13 | 44±13 | 47±13 | 0.06 |
| Male | 61.7% | 65.3% | 53.6% | 0.05 |
| Asian | 96.2% | 99.5% | 88.7% | <0.0001 |
| HBeAg-Positive | 37.5% | 45.7% | 22.3% | <0.0001 |
| Baseline ALT, U/L | 61 (41–104) | 61 (41–106) | 60 (42–102) | 0.95 |
| Baseline HBV DNA, log10 IU/mL | 5.9 (4.6–7.5) | 6.1 (4.8–7.4) | 5.5 (4.0–7.6) | 0.03 |
| Cirrhosis | 9.8% | 9.1% | 11.3% | 0.54 |
Values are presented as mean±SD, proportions, or median (IQR).
ALT, alanine aminotransferase; GI, gastroenterology; HBeAg, hepatitis B e antigen; HBV DNA, hepatitis B virus DNA.